Pharmaceuticals





Biopharmaceuticals
Pharmaceuticals
Stock Picks
Value Investing

2 Value Stocks That Are Stupid Cheap Right Now

Good bargains may be hard to come by right now, but these 2 stocks look ripe for the picking.

Read More
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Ironwood Pharmaceuticals, Inc. (IRWD) Buy Target $12.97 – Sell Target $14.80

Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and CONSTELLA […]

Read More
Defensive Stocks
Fibonacci Retracement
Fundamental Analysis
Health
InvestivDaily
Pharmaceuticals
Technical Analysis
Value Investing

Should you buy PRGO’s big discount?

The market’s rally from a low point on Christmas Eve last year has given a lot of investors reason to think that the worst of the correction before that, which tested bear market territory for all of the major market indices, is probably done. With seemingly positive news on the trade front working along with […]

Read More
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Rigel Pharmaceuticals, Inc. (RIGL) Buy Target $2.60 – Sell Target $4.37

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of small molecule drugs for the treatment of immune and hematologic disorders, cancer, and rare diseases. The company’s clinical programs include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; and Phase III clinical study […]

Read More
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Tenax Therapeutics, Inc. (TENX) Buy Target $2.29 – Sell Target $5.78

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction […]

Read More
Biopharmaceuticals
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Curis, Inc. (CRIS) Buy Signal $1.28 – Sell Signal $2.17

Curis, Inc., a biotechnology company, focuses on the development and commercialization of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CUDC-907, an oral dual inhibitor of HDAC and PI3K enzymes, which is in Phase II clinical trial for the treatment of patients with MYC-altered diffuse […]

Read More
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Innoviva, Inc. (INVA) Buy Target $15.25 – Sell Target $19.75

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a long-acting beta2 agonist (LABA), […]

Read More
Daily Perspective
Pharmaceuticals

CVS Stock Will Likely Rebound as the Company Spearheads a Healthcare Revolution

CVS Health Corp. (CVS) reported Q4 earnings on Wednesday, and the company disappointed with a lower-than-expected earnings forecast for the rest of 2019. Investors primarily focused on the weak guidance over earnings per share (EPS), which surpassed Wall Street estimates by a solid margin. Today’s performance marks a seismic shift in the company’s history from […]

Read More
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company offers ARO-AAT, a RNA interference (RNAi) therapeutic candidate for the treatment of liver disease related to alpha-1 antitrypsin deficiency; ARO-APOC3 to treat hypertriglyceridemia; ARO-ANG3 to reduce production of angiopoietin-like protein 3; ARO-ENaC to reduce production of the epithelial […]

Read More
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Progenics Pharmaceuticals, Inc. (PGNX)

Progenics Pharmaceuticals, Inc. develops medicines and other technologies to target and treat cancer in the United States and internationally. The company’s primary clinical-stage product candidates include Azedra, a radiotherapeutic product candidate, which is in Phase IIb clinical trial under special protocol assessment for the treatment of malignant, recurrent, and/or unresectable pheochromocytoma and paraganglioma; 1404, a […]

Read More